MilliporeSigma Opens China’s First BioReliance® End-to-End Biodevelopment Center in Shanghai

Located in Shanghai, China, the center will provide a full range of process development capabilities and services, including cell line development, upstream and downstream process development and non-GMP clinical production. “Our new BioReliance ® End-to …
( read original story …)


Related Post